David C. Gale
Keine laufenden Positionen mehr
Profil
David C.
Gale worked as Vice President-Research & Development at Artivion, Inc. and Intersect ENT, Inc. from 2007 to 2009.
He received his undergraduate and graduate degrees from The University of Manchester and a graduate degree from Auburn University.
He also earned a doctorate degree from The University of Alabama.
Ehemalige bekannte Positionen von David C. Gale
| Unternehmen | Position | Ende |
|---|---|---|
| INTERSECT ENT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2009 |
| ARTIVION, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von David C. Gale
| The University of Alabama | Doctorate Degree |
| Auburn University | Graduate Degree |
| The University of Manchester | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARTIVION, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
